Bibliographic citations
Ariza, F., (2013). Diseño de un manual de buenas prácticas de manufactura de radiofármacos para tomografía por emisión de positrones y su implementación en un centro radiofarmacéutico PET [Tesis, Universidad Nacional Mayor de San Marcos]. https://hdl.handle.net/20.500.12672/2873
Ariza, F., Diseño de un manual de buenas prácticas de manufactura de radiofármacos para tomografía por emisión de positrones y su implementación en un centro radiofarmacéutico PET [Tesis]. PE: Universidad Nacional Mayor de San Marcos; 2013. https://hdl.handle.net/20.500.12672/2873
@phdthesis{renati/486709,
title = "Diseño de un manual de buenas prácticas de manufactura de radiofármacos para tomografía por emisión de positrones y su implementación en un centro radiofarmacéutico PET",
author = "Ariza Alva, Freddy Félix",
publisher = "Universidad Nacional Mayor de San Marcos",
year = "2013"
}
--- In 1989, the “Instituto Peruano de Energía Nuclear (IPEN)” started the production of radioisotopes in Peru since been progressively incorporated iodine-labeled radiopharmaceuticals, technetium, and other radioisotopes for nuclear medicine. In 2010, a private company (Ciclotrón Perú S.A.) starts the production of radiopharmaceuticals for positron emission tomography (PET radiopharmaceuticals) and now, Social Security of Peru (EsSalud) has acquired a cyclotron to initiate the production of PET radiopharmaceuticals in 2013. These developments have motivated to propose a “Good Manufacturing Practices Manual for Positron Emission Tomography Radiopharmaceuticals“ as well as it implementation integrated with the ISO 9001:2008 Quality Management System. Radiopharmaceuticals should comply with regulations applicable to medicines established by the Dirección General de Medicamentos, Insumos y Drogas (DIGEMID) and rules on the use of radioactive materials established by the Instituto Peruano de Energía Nuclear (IPEN) through the Oficina Técnica de la Autoridad Nacional (OTAN). The design of the “Good Manufacturing Practices Manual for Positron Emission Tomography Radiopharmaceuticals“ presents three stages: compilation and review of national regulations applicable to the manufacture of radiopharmaceuticals, review and analysis of international documents and manual elaboration. Likewise raises a number of stages for the implementation of the Good Manufacturing Practices Manual for Positron Emission Tomography Radiopharmaceuticals integrated with the ISO 9001:2008 Quality Management System, which will minimize costs, bureaucracy, documentation, etc., in favor of the maintenance and continuous improvement throughout the organization, ensured the development of a drug safe, effective and quality. Keywords: Good Manufacturing Practices, radiopharmaceuticals for positron emission tomography, Quality Management System.
This item is licensed under a Creative Commons License